Latest News

Nemolizumab beats placebo for reduction of pruritus in eczema

(HealthDay)—For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine.

Source link

Related posts

Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?


Cognitive neuropsychiatric analysis of an additional large Capgras delusion case series


Halo Labs Provides California Update


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World